– USA, CA – Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of transformational technologies for the treatment of cardiovascular disease, today announced the appointment of Kevin Ballinger to its Board of Directors effective immediately.
Kevin Ballinger will also join the Nominating and ESG Committee and the Compensation Committee.
About Kevin Ballinger
Kevin Ballinger, who is a recognized leader in the healthcare industry with over 25 years of professional experience, has served since July 2020 as President of Aldevron, LLC, a privately held genomics company that Danaher Corporation acquired in August 2021. He also served as a member of Aldevron’s board of directors from July 2020 until the acquisition by Danaher. Before joining Aldevron, he spent 25 years at Boston Scientific Corporation, a publicly traded global company focused on various interventional medical specialties. During his last nine years at Boston Scientific, Mr. Ballinger served as EVP and Global President of the Interventional Cardiology division. Mr. Ballinger has served on the board of directors of Silk Road Medical, Inc., a medical device company, since December 2020.
Mr. Ballinger earned his B.S. in Mechanical Engineering from Michigan Technological University and his M.B.A. from the University of Minnesota’s Carlson School of Management.
About Shockwave Medical, Inc.
Shockwave Medical is a leader in developing and commercializing innovative products that are transforming the treatment of cardiovascular disease. Its first-of-its-kind Intravascular Lithotripsy technology has transformed the treatment of atherosclerotic cardiovascular disease by safely using sonic pressure waves to disrupt challenging calcified plaque, resulting in significantly improved patient outcomes. Shockwave has also recently acquired the Neovasc Reducer, under clinical investigation in the United States and CE Marked in the European Union and the United Kingdom. By redistributing blood flow within the heart, the Reducer is designed to provide relief to millions of patients worldwide suffering from refractory angina.
Source: https://shockwavemedical.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.